The Food and Drug Administration has permanently revoked the certificate of product registration (CPR) of anti-dengue vaccine Dengvaxia, which has been blamed for a slump in immunization rates.
Full Story here
Reblogged by Visayan Business Post - Local News for the Global Visayan
Full Story here
Reblogged by Visayan Business Post - Local News for the Global Visayan
No comments:
Post a Comment